Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy

References

• SokkaTAbelsonBPincusTMortality in rheumatoid arthritis: 2008 updateClin Exp Rheumatol2008265 Suppl 51S35S6119026144
   PubMed Web of Science ®Google Scholar
• GabrielSEMichaudKEpidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseasesArthritis Res Ther200911322919519924
   PubMed Web of Science ®Google Scholar
• KavanaughACohenSCushJJThe evolving use of tumor necrosis factor inhibitors in rheumatoid arthritisJ Rheumatol200431101881188415468347
   PubMed Web of Science ®Google Scholar
• DonahueKEGartlehnerGJonasDESystematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritisAnn Intern Med2008148212413418025440
   PubMed Web of Science ®Google Scholar
• BreedveldFCWeismanMHKavanaughAFet al; The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis Rheum2006541263716385520
   PubMed Web of Science ®Google Scholar
• KlareskogLvan der HeijdeDde JagerJPTherapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trialLancet2004363941067568115001324
   PubMed Web of Science ®Google Scholar
• van der HeijdeDKlareskogLSinghAPatient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trialAnn Rheum Dis200665332833416079172
   PubMed Web of Science ®Google Scholar
• van der HeijdeDKlareskogLRodriguez-ValverdeVComparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trialArthritis Rheum20065441063107416572441
   PubMed Web of Science ®Google Scholar
• BathonJMMartinRWFleischmannRMA comparison of etanercept and methotrexate in patients with early rheumatoid arthritisN Engl J Med2000343221586159311096165
   PubMed Web of Science ®Google Scholar
• LeeSJKremerJKavanaughATreatment disparity related to race/ethnicity and education in rheumatoid arthritis patients: comment on the article by Constantinescu, et alArthritis Rheum20096181141114219644891
   PubMed Web of Science ®Google Scholar
• JacobiCEMolGDBoshuizenHCRuppIDinantHJVan Den BosGAImpact of socioeconomic status on the course of rheumatoid arthritis and on related use of health care servicesArthritis Rheum200349456757312910565
   PubMed Web of Science ®Google Scholar
• PincusTKeysorJSokkaTKrishnanECallahanLFPatient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practicesJ Rheumatol200431222923414760789
   PubMed Web of Science ®Google Scholar
• IrenUTWalkerMSHochmanEBrasingtonRA pilot study to determine whether disability and disease activity are different in African-American and Caucasian patients with rheumatoid arthritis in St. Louis, Missouri, USAJ Rheumatol200532460260815801013
   PubMed Web of Science ®Google Scholar
• JordanJMEffect of race and ethnicity on outcomes in arthritis and rheumatic conditionsCurr Opin Rheumatol19991129810310319211
   PubMedGoogle Scholar
• KatzJNPreferences, disparities, and the authenticity of patient choicesJ Rheumatol Suppl200368121414725248
   PubMedGoogle Scholar
• SmedleyBStithAYNelsonARUnequal Treatment: Confronting Racial and Ethnic Disparities in Health CareWashington, DCInstitute of Medicine2003
   Google Scholar
• MartinRWHeadAJReneJPatient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physicianJ Rheumatol200835461862418278840
   PubMed Web of Science ®Google Scholar
• SaagKGTengGGPatkarNMAmerican College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritisArthritis Rheum200859676278418512708
   PubMed Web of Science ®Google Scholar
• MarshallNJWilsonGLapworthKKayLJPatients’ perceptions of treatment with anti-TNF therapy for rheumatoid arthritis: a qualitative studyRheumatology (Oxford)20044381034103815150436
   PubMed Web of Science ®Google Scholar
• van TuylLHPlassAMLemsWFDiscordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritisRheumatology (Oxford)200847101571157618710900
   PubMed Web of Science ®Google Scholar
• CarbonellJBadiaXExpectations, preferences and satisfaction of patients with rheumatoid arthritis receiving infliximab treatmentMed Clin (Barc)20081311349349919007577
   PubMed Web of Science ®Google Scholar
• KjekenIDagfinrudHMowinckelPUhligTKvienTKFinsetARheumatology care: Involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitisArthritis Rheum200655339440116739186
   PubMed Web of Science ®Google Scholar
• RaoJKWeinbergerMAndersonLAKroenkeKPredicting reports of unmet expectations among rheumatology patientsArthritis Rheum200451221522115077262
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudKResistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients’ treatment choicesArthritis Rheum20075672135214217599730
   PubMed Web of Science ®Google Scholar
• Garcia-GonzalezARichardsonMGarcia Popa-LisseanuMTreatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosusClin Rheumatol200827788388918185905
   PubMed Web of Science ®Google Scholar
• SteinerJFEarnestMAThe language of medication-takingAnn Intern Med20001321192693010836931
   PubMed Web of Science ®Google Scholar
• GrijalvaCGChungCPArbogastPGSteinCMMitchelEFJrGriffinMRAssessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritisMed Care20074510 Suppl 2S66S7617909386
   PubMed Web of Science ®Google Scholar
• HarleyCRFrytakJRTandonNTreatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexateAm J Manag Care200396 SupplS136S14314577718
   PubMed Web of Science ®Google Scholar
• WendlingDMaterneGEMichelFInfliximab continuation rates in patients with rheumatoid arthritis in everyday practiceJoint Bone Spine200572430931216038842
   PubMed Web of Science ®Google Scholar
• ChungCMallonCSpadyBRussellASMaksymovychWPSurvival Analysis of Treatment with Leflunomide, Combination Leflunomide/Methotrexate, and Infliximab for Rheumatoid Arthritis in Routine Clinical PracticeArthritis Rheum200348Suppl 9S334
   Google Scholar
• FlendrieMCreemersMCWelsingPMden BroederAAvan RielPLSurvival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritisAnn Rheum Dis200362Suppl 2ii30ii3314532145
   PubMed Web of Science ®Google Scholar
• ZinkAListingJKarySTreatment continuation in patients receiving biological agents or conventional DMARD therapyAnn Rheum Dis20056491274127915708884
   PubMed Web of Science ®Google Scholar
• KristensenLESaxneTNilssonJAGeborekPImpact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern SwedenArthritis Res Ther200686R17417121678
   PubMed Web of Science ®Google Scholar
• NeameRHammondABeliefs about medications: a questionnaire survey of people with rheumatoid arthritisRheumatology (Oxford)200544676276715741193
   PubMed Web of Science ®Google Scholar
• KumarKGordonCToescuVBeliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and White British originRheumatology (Oxford)200847569069718375972
   PubMed Web of Science ®Google Scholar
• TreharneGJLyonsACHaleEDDouglasKMKitasGDPredictors of medication adherence in people with rheumatoid arthritis: studies are necessary but non-validated measures of medication adherence are of concernRheumatology (Oxford)200544101330 author reply 133115972349
   PubMed Web of Science ®Google Scholar
• CurkendallSPatelVGleesonMCampbellRSZagariMDuboisRCompliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter?Arthritis Rheum200859101519152618821651
   PubMed Web of Science ®Google Scholar
• LimAYEllisCBrooksbyAGaffneyKPatient satisfaction with rheumatology practitioner clinics: can we achieve concordance by meeting patients’ information needs and encouraging participatory decision making?Ann Acad Med Singapore200736211011417364077
   PubMed Web of Science ®Google Scholar
• JefferyMStokesAJohnsonKAndersonDHarperBHons PoliticsBAPatient Preferences for Tumor Necrosis Factor (TNF) AntagonistLondon, UK and Dallas, TXThe Research Partnership Ltd, Rheumatology Research International2004
   Google Scholar
• FraenkelLBogardusSTConcatoJFelsonDTWittinkDRPatient preferences for treatment of rheumatoid arthritisAnn Rheum Dis200463111372137815020312
   PubMed Web of Science ®Google Scholar
• WilliamsELEdwardsCJPatient preferences in choosing anti-TNF therapies-R1Rheumatology (Oxford)200645121575157617085468
   PubMed Web of Science ®Google Scholar
• Goekoop-RuitermanYPde Vries-BouwstraJKAllaartCFPatient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)Ann Rheum Dis20076691227123217405834
   PubMed Web of Science ®Google Scholar
• ChiltonFCollettRATreatment choices, preferences and decision-making by patients with rheumatoid arthritisMusculoskeletal Care20086111417726671
   PubMedGoogle Scholar
• ConstantinescuFGoucherSWeinsteinAFraenkelLRacial disparities in treatment preferences for rheumatoid arthritisMed Care200947335035519165120
   PubMed Web of Science ®Google Scholar
• ConstantinescuFGoucherSWeinsteinASmithWFraenkelLUnderstanding why rheumatoid arthritis patient treatment preferences differ by raceArthritis Rheum200961441341819333986
   PubMed Web of Science ®Google Scholar
• BarlowJHCullenLARoweIFEducational preferences, psychological well-being and self-efficacy among people with rheumatoid arthritisPatient Educ Couns2002461111911804765
   PubMed Web of Science ®Google Scholar
• van den BemtBJvan LankveldWGHow can we improve adherence to therapy by patients with rheumatoid arthritis?Nat Clin Pract Rheumatol200731268118037928
   PubMedGoogle Scholar
• HetlandMLLindegaardHMHansenADo changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO RegistryAnn Rheum Dis20086771023102618272669
   PubMed Web of Science ®Google Scholar
• Rheumatoid Arthritis Medicines: A Guide for Adults AHRQ Pub. No. 08-EHC004-2A42008Agency for Healthcare Research and QualityRockville, MD
   Google Scholar